Skip to content
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening […]
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
Two issues critical for the biotech sector kept busy Capitol Hill on March 16: the collapse of Silicon Valley Bank (SVB) and Mexico’s biotech
SVB collapse and Mexico corn ban consultations keep Capitol Hill busy Read More »
We are still discovering novel ways that biodiesel can help reduce our environmental footprint, but the idea of using this alternative fuel is not
Biodiesel Day celebrates a cutting-edge innovation discovered more than a century ago Read More »
The makers of more than a dozen prescription drugs covered by Medicare are seeing the first impacts of the Inflation Reduction Act (IRA) passed
CMS announces penalties on 27 prescription drugs, draft guidance on price controls Read More »
Agriculture is essential to the U.S. economy – and to put food on the table for American families. And more than ever, it’s critical
Plant Biostimulant Act would offer clear market path for important ag biotech Read More »
Biotechnology Innovation Organization (BIO) members Bristol Myers’, Pfizer’s, and AbbVie’s drugs “are likely to be among 10 big-selling medicines subject to U.S. price negotiations
U.S. drug price negotiation already affecting Bristol Myers, Pfizer, AbbVie Read More »
America’s largest integrated healthcare system, the Veterans Health Administration (VHA), will be providing coverage of LEQEMBI (lecanemab-irmb) “to veterans living with early stages of
VHA is the first major insurer to cover Alzheimer’s drug LEQEMBI Read More »
While it deliberates on whether to support the expansion of the international waiver of IP protections for COVID-19 therapeutics and diagnostics, the United States
Last chance for public hearing on the COVID IP waiver expansion Read More »
In recent years, Artificial Intelligence (AI) has boomed in healthcare. AI is helping scientists obtain relevant data, accurately predict diseases at early stages, and
I am BIO Podcast: How AI and biotech can ‘run evolution at hyperspeed’ Read More »
On Friday, March 10, 2023, the United States Food and Drug Administration (FDA) approved Acadia Pharmaceuticals’ drug for genetic Rett syndrome, the company announced
FDA approves Acadia’s DAYBUE for the treatment of Rett syndrome Read More »
